|
Name |
4-Hydroxy-6-methyl-2-pyrone
|
Molecular Formula | C6H6O3 | |
IUPAC Name* |
4-hydroxy-6-methylpyran-2-one
|
|
SMILES |
CC1=CC(=CC(=O)O1)O
|
|
InChI |
InChI=1S/C6H6O3/c1-4-2-5(7)3-6(8)9-4/h2-3,7H,1H3
|
|
InChIKey |
NSYSSMYQPLSPOD-UHFFFAOYSA-N
|
|
Synonyms |
4-Hydroxy-6-methyl-2-pyrone; 675-10-5; 2-Hydroxy-6-methyl-4H-pyran-4-one; 4-Hydroxy-6-methyl-2H-pyran-2-one; 70254-61-4; 4-hydroxy-6-methylpyran-2-one; Triacetic acid lactone; Triacetate lactone; 2H-PYRAN-2-ONE, 4-HYDROXY-6-METHYL-; 6-Methyl-4-hydroxypyron-(2); NSC 34625; MFCD00006641; CHEMBL54907; S1S883S4EE; 6-Methyl-4-hydroxypyran-2-one; CHEBI:16458; 6-methyl-4-oxidanyl-pyran-2-one; NSC-34625; 3,5-Dihydroxysorbic acid delta-lactone; 6-methyl-4-hydroxy-2-pyrone; 4-Hydroxy-6-methylpyran-4-one; CCRIS 3600; EINECS 211-619-2; BRN 0113815; UNII-S1S883S4EE; 4H-Pyran-4-one, 2-hydroxy-6-methyl-; Spectrum_001904; SpecPlus_000816; Spectrum2_001978; Spectrum3_001720; Spectrum4_001907; Spectrum5_000594; 4-hydroxy-6-methylpyrone; 6-methyl-4-hydroxypyrone; 4-hydroxy-6-methyl-pyrone; 4-hydroxy-6-methylpyranone; 4-hydroxy-6-methyl pyranone; BSPBio_003340; KBioGR_002500; KBioSS_002438; 4-hydoxy-6-methyl-2-pyrone; DivK1c_006912; SCHEMBL320025; SCHEMBL918518; SPECTRUM1600759; SPBio_002135; 4- hydoxy-6-methyl-2-pyrone; 4-hydroxy- 6-methyl-2-pyrone; 4-hydroxy-6 -methyl-2-pyrone; 4-hydroxy-6-methyl pyr-2-one; DTXSID1060974; KBio1_001856; KBio2_002432; KBio2_005000; KBio2_007568; KBio3_002560; 4-hydroxy-6-methyl-pyran-2-one; 6-methyl-4-hydroxy pyran-2-one; 3,5-Dihydroxysorbic acid d-lactone; ALBB-021321; AMY23278; NSC34625; ZINC4273393; BBL008420; BDBM50405204; CCG-39516; MFCD18820248; STK772128; 4-Hydroxy-6-methyl-2-pyrone, 98%; AKOS000119605; AKOS016007260; ZINC100045433; CS-W020045; SDCCGMLS-0066925.P001; NCGC00095976-01; NCGC00095976-02; NCGC00178130-01; AC-27196; DA-17115; SY001948; 4-HYDROXY-6-METHYL-.ALPHA.-PYRONE; DB-055039; CS-0061284; FT-0618665; FT-0715301; H0715; EN300-20217; 75H105; 7H-939; C02752; F14831; O10801; A866649; SR-05000002374; Q7839869; SR-05000002374-1; W-104713; BRD-K77202630-001-02-9; BRD-K77202630-001-03-7; SORBIC ACID, 3,5-DIHYDROXY-, .DELTA.-LACTONE; F0001-1779; Z104477314; KJ6
|
|
CAS | 675-10-5 | |
PubChem CID | 54675757 | |
ChEMBL ID | CHEMBL54907 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 126.11 | ALogp: | 0.5 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.565 |
Caco-2 Permeability: | -4.627 | MDCK Permeability: | 0.00003070 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.944 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.049 |
30% Bioavailability (F30%): | 0.836 |
Blood-Brain-Barrier Penetration (BBB): | 0.066 | Plasma Protein Binding (PPB): | 71.01% |
Volume Distribution (VD): | 0.645 | Fu: | 44.53% |
CYP1A2-inhibitor: | 0.299 | CYP1A2-substrate: | 0.772 |
CYP2C19-inhibitor: | 0.037 | CYP2C19-substrate: | 0.115 |
CYP2C9-inhibitor: | 0.012 | CYP2C9-substrate: | 0.851 |
CYP2D6-inhibitor: | 0.02 | CYP2D6-substrate: | 0.642 |
CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.217 |
Clearance (CL): | 8.969 | Half-life (T1/2): | 0.781 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.062 |
Drug-inuced Liver Injury (DILI): | 0.415 | AMES Toxicity: | 0.059 |
Rat Oral Acute Toxicity: | 0.108 | Maximum Recommended Daily Dose: | 0.048 |
Skin Sensitization: | 0.253 | Carcinogencity: | 0.657 |
Eye Corrosion: | 0.956 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.564 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004676 | 0.442 | D0FA2O | 0.315 | ||||
ENC001617 | 0.442 | D07EXH | 0.297 | ||||
ENC005178 | 0.442 | D0N0OU | 0.282 | ||||
ENC001542 | 0.442 | D06GIP | 0.233 | ||||
ENC005370 | 0.442 | D02UFG | 0.231 | ||||
ENC001539 | 0.429 | D0E9CD | 0.227 | ||||
ENC005125 | 0.429 | D04AIT | 0.224 | ||||
ENC006014 | 0.413 | D0G4KG | 0.222 | ||||
ENC003365 | 0.413 | D08ZEB | 0.222 | ||||
ENC000353 | 0.371 | D07GRH | 0.222 |